CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Open-market buy COO and Chief Medical Officer bought 3,000 shares at $3.88 ($11,640)
- 4 Open-market buy EVP, CFO and Treasurer bought 11,600 shares at $3.96 ($45,929)
- 4 Open-market buy Chief Commercial Officer bought 3,000 shares at $3.90 ($11,700)
- 4 Grant or award EVP, CFO and Treasurer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 13,332 shares at $3.67 ($48,891)
- 4 Grant or award Lebovits Chaim acquired 31,185 shares (grant or award)
- 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
- 4 Grant or award Director acquired 3,501 shares (grant or award)
- 4 Open-market buy Director bought 1,475 shares at $3.39 ($5,000)
- 4 Gift Director gave 121,558 shares (gift)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 3,667 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Returned to the company Chief Commercial Officer returned 2,805 shares (to the company)
Page 6 of 17 · 329 filings